10 reports

  • MAB PIPELINE BY COMPANY AND STAGE OF DEVELOPMENT
  • MAB PIPELINE BY COMPANY AND STAGE OF DEVELOPMENT

Detection of human immunodeficiency virus type ## (HIV-##) antibody by western blotting and HIV-## DNA by PCR in patients with AIDS.

  • Biopharmaceutical
  • Medical Biotechnology
  • Monoclonal Antibody
  • AbbVie Inc.
  • Xencor, Inc.
  • XENCOR - 3/3

Product REZEPTA BIOPHARMA ID No.

  • Biopharmaceutical
  • Cancer Immunotherapy
  • Therapy
  • AstraZeneca PLC
  • Xencor, Inc.

Name SSS##; TRPH ##; TPMC-##; DIG-KT Target / Mechanism of Action ## ## WUHAN YZY BIOPHARMA - ##/ ## ID No.

  • Biopharmaceutical
  • Cancer
  • Immunotherapy
  • Affimed Therapeutics AG
  • Xencor, Inc.

Name SSS##; TRPH ##; TPMC-##; DIG-KT Target / Mechanism of Action ## ## WUHAN YZY BIOPHARMA - ##/ ## ID No.

  • Biopharmaceutical
  • Cancer
  • Immunotherapy
  • Affimed Therapeutics AG
  • Xencor, Inc.
  • 6. Profiles of Anti-CD123 Immunotherapeutics

Seattle Genetics has licensed its auristatin- and PBD-based ADC technology to a number of biopharmaceutical companies.

  • Biopharmaceutical
  • Immunotherapy
  • Cellectis S.A.
  • Janssen Biotech, Inc.
  • Xencor, Inc.
  • ENGINEERED ANTIBODIES

CTI BIOPHARMA ##.

  • Biopharmaceutical
  • North America
  • United States
  • Forecast
  • Xencor, Inc.
  • PARTNERSHIPS
  • XENCOR COMPLETES IPO FOR US$80.5 MILLION

Completed ##-Jul-2013 ## Maximum Value (US$ m) ## ## Cash (US$ m) Product Description Antibody for Monoclonal antibody was under development for the treatment of autoimmune diseases.

  • Biopharmaceutical
  • Therapy
  • United States
  • Company
  • Xencor, Inc.
  • TEPLIZUMAB - DRUG PROFILE
  • T-Cell Surface Glycoprotein CD3 Epsilon Chain (T-Cell Surface Antigen T3/Leu-4 Epsilon Chain or CD3e) - Featured News & Press Releases

Participants were allocated ##:##:##:## to receive daily infusions of teplizumab (full dose for ## days, ##/ ## dose for ## days, or full dose for six days) or placebo at baseline and at six months.

  • Biopharmaceutical
  • Immunotherapy
  • Monoclonal Antibody
  • Type 1 Diabetes
  • Xencor, Inc.

AMGEN & AMGEN ASTELLAS BIOPHARMA - ##/ ## ID No.

  • Biopharmaceutical
  • Immunotherapy
  • Lymphoma
  • Medical Biotechnology
  • Xencor, Inc.

Approximately ## SLE patients will be enrolled with a ##:## randomization of XmAb## to placebo.

  • Biopharmaceutical
  • Immunotherapy
  • United States
  • Company Operations
  • Xencor, Inc.